𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Astro plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: A randomized study of 353 patients

✍ Scribed by Rodrigo Arriagada; Thierry le Chevalier; Elizabeth Quoix; Pierre Ruffie; Hubert de Cremoux; Jean-Yves Douillard; Michéle Tarayre; Jean-Pierre Pignon; Agnès Laplanche; the GETCB; the FNCLCC; the CEBI trialist

Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
981 KB
Volume
20
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective randomized study of four nov
Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network trial
✍ F. Anthony Greco; James R. Gray Jr.; Dana S. Thompson; Howard A. Burris III; Joa 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND The authors compared the toxicity, response rate, and progression free survival of four chemotherapy regimens for patients with advanced (Stage IIIB and IV) nonsmall cell lung carcinoma. ## METHODS A total of 267 patients entered this randomized Phase II trial on one of

The addition of cisplatin to cyclophosph
The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma : A randomized study of 457 patients
✍ Thierry Urban; Claude Chastang; François-Xavier Lebas; Jean-Paul Duhamel; Guy Ad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel

Prolonged gemcitabine infusion in advanc
Prolonged gemcitabine infusion in advanced non–small cell lung carcinoma : A randomized Phase II study of two different schedules in combination with cisplatin
✍ Anna Ceribelli; Cesare Gridelli; Filippo De Marinis; Alessandra Fabi; Teresa Gam 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND Preclinical and clinical evidence suggests that a fixed infusion rate of 10 mg/m^2^ per minute may be more effective than the standard 30‐minute infusion of gemcitabine. To investigate the activity and toxicity of the cisplatin plus gemcitabine combination with gemcitabin